Relafen 750, chemically identified as naproxol, exemplifies a fascinating case study from a biochemical medicinal viewpoint. Its process of diminishing inflammation involves the targeted inhibition of cyclooxygenase-2 (COX-2), an enzyme essential for the production of prostanoids, potent agents of inflammation and pain. Unlike traditional NSAIDs, R